These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37239824)

  • 1. Dipeptide Nitrile CD34 with Curcumin: A New Improved Combination Strategy to Synergistically Inhibit Rhodesain of
    Di Chio C; Previti S; Totaro N; De Luca F; Allegra A; Schirmeister T; Zappalà M; Ettari R
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Combination Studies of the Dipeptide Nitrile CD24 with Curcumin: A New Strategy to Synergistically Inhibit Rhodesain of
    Di Chio C; Previti S; De Luca F; Bogacz M; Zimmer C; Wagner A; Schirmeister T; Zappalà M; Ettari R
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense.
    Di Chio C; Previti S; Amendola G; Ravichandran R; Wagner A; Cosconati S; Hellmich UA; Schirmeister T; Zappalà M; Ettari R
    Eur J Med Chem; 2022 Jun; 236():114328. PubMed ID: 35385806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Synergism: Studies of Combination of RK-52 and Curcumin against Rhodesain of
    Ettari R; Previti S; Di Chio C; Maiorana S; Allegra A; Schirmeister T; Zappalà M
    ACS Med Chem Lett; 2020 May; 11(5):806-810. PubMed ID: 32435388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug combination studies of curcumin and genistein against rhodesain of
    Ettari R; Previti S; Maiorana S; Allegra A; Schirmeister T; Grasso S; Zappalà M
    Nat Prod Res; 2019 Dec; 33(24):3577-3581. PubMed ID: 29897253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of dipeptide nitriles as inhibitors of rhodesain, a major cysteine protease of Trypanosoma brucei.
    Schirmeister T; Schmitz J; Jung S; Schmenger T; Krauth-Siegel RL; Gütschow M
    Bioorg Med Chem Lett; 2017 Jan; 27(1):45-50. PubMed ID: 27890381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug combination studies of PS-1 and quercetin against rhodesain of
    Di Chio C; Previti S; De Luca F; Allegra A; Zappalà M; Ettari R
    Nat Prod Res; 2022 Aug; 36(16):4282-4286. PubMed ID: 34533390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense.
    Di Chio C; Previti S; Amendola G; Cosconati S; Schirmeister T; Zappalà M; Ettari R
    ChemMedChem; 2020 Jun; 15(11):995-1001. PubMed ID: 32329206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New peptidomimetic rhodesain inhibitors with improved selectivity towards human cathepsins.
    Jung S; Fuchs N; Grathwol C; Hellmich UA; Wagner A; Diehl E; Willmes T; Sotriffer C; Schirmeister T
    Eur J Med Chem; 2022 Aug; 238():114460. PubMed ID: 35597010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
    Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
    Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the Reversible and Irreversible Inhibition of Rhodesain by Curcumin.
    Steverding D
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31905815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain.
    McShan D; Kathman S; Lowe B; Xu Z; Zhan J; Statsyuk A; Ogungbe IV
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4509-12. PubMed ID: 26342866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense.
    Caffrey CR; Hansell E; Lucas KD; Brinen LS; Alvarez Hernandez A; Cheng J; Gwaltney SL; Roush WR; Stierhof YD; Bogyo M; Steverding D; McKerrow JH
    Mol Biochem Parasitol; 2001 Nov; 118(1):61-73. PubMed ID: 11704274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2 H-1,2,3-Triazole-Based Dipeptidyl Nitriles: Potent, Selective, and Trypanocidal Rhodesain Inhibitors by Structure-Based Design.
    Giroud M; Kuhn B; Saint-Auret S; Kuratli C; Martin RE; Schuler F; Diederich F; Kaiser M; Brun R; Schirmeister T; Haap W
    J Med Chem; 2018 Apr; 61(8):3370-3388. PubMed ID: 29590751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved trypanocidal activities of cathepsin L inhibitors.
    Nkemgu NJ; Grande R; Hansell E; McKerrow JH; Caffrey CR; Steverding D
    Int J Antimicrob Agents; 2003 Aug; 22(2):155-9. PubMed ID: 12927956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies.
    Jung S; Fuchs N; Johe P; Wagner A; Diehl E; Yuliani T; Zimmer C; Barthels F; Zimmermann RA; Klein P; Waigel W; Meyr J; Opatz T; Tenzer S; Distler U; Räder HJ; Kersten C; Engels B; Hellmich UA; Klein J; Schirmeister T
    J Med Chem; 2021 Aug; 64(16):12322-12358. PubMed ID: 34378914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of triazine nitriles as rhodesain inhibitors: structure-activity relationships, bioisosteric imidazopyridine nitriles, and X-ray crystal structure analysis with human cathepsin L.
    Ehmke V; Winkler E; Banner DW; Haap W; Schweizer WB; Rottmann M; Kaiser M; Freymond C; Schirmeister T; Diederich F
    ChemMedChem; 2013 Jun; 8(6):967-75. PubMed ID: 23658062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).
    Previti S; Ettari R; Cosconati S; Amendola G; Chouchene K; Wagner A; Hellmich UA; Ulrich K; Krauth-Siegel RL; Wich PR; Schmid I; Schirmeister T; Gut J; Rosenthal PJ; Grasso S; Zappalà M
    J Med Chem; 2017 Aug; 60(16):6911-6923. PubMed ID: 28763614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidyl Vinyl Ketone Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment.
    Maiorana S; Ettari R; Previti S; Amendola G; Wagner A; Cosconati S; Hellmich UA; Schirmeister T; Zappalà M
    ChemMedChem; 2020 Aug; 15(16):1552-1561. PubMed ID: 32567172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure, interdomain dynamics, and pH-dependent autoactivation of pro-rhodesain, the main lysosomal cysteine protease from African trypanosomes.
    Johé P; Jaenicke E; Neuweiler H; Schirmeister T; Kersten C; Hellmich UA
    J Biol Chem; 2021; 296():100565. PubMed ID: 33745969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.